Finance

Lists
Why is I1SR34 up 2,14%?
Dive Deeper
I1SR34:BVMF
Intuitive Surgical Inc Bdr
107,52 BRL
+2,14%
(+2,25) 1D
15-окт., 12:10:19 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for I1SR34...
Open
107,14 BRL
High
107,52 BRL
Low
106,90 BRL
Mkt. cap
149,84 млд
Avg. vol.
1,43 миң
Volume
654,00
52-wk high
162,55 BRL
52-wk low
83,81 BRL
Shares outstanding
353,28 млн
No. of employees
17 миң
Open
107,14 BRL
High
107,52 BRL
Low
106,90 BRL
Mkt. cap
149,84 млд
Avg. vol.
1,43 миң
Volume
654,00
52-wk high
162,55 BRL
52-wk low
83,81 BRL
Shares outstanding
353,28 млн
No. of employees
17 миң
News stories
From web sources and news partners
Profile
Intuitive Surgical, Inc. is an American biotechnology company that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the Nasdaq-100, S&P 100 and S&P 500. As of 31 December 2021, Intuitive Surgical had an installed base of 6,730 da Vinci Surgical Systems, including 4,139 in the U.S., 1,199 in Europe, 1,050 in Asia, and 342 in the rest of the world. Intuitive Surgical first appeared on the Fortune 500 in 2024 at number 497; in 2025 the company rose to number 459 overall and ranked 43rd within the healthcare sector. Wikipedia
About Intuitive Surgical Inc Bdr
CEODavid J. Rosa
Employees17 миң
Founded1995
HeadquartersСаннивейл, Калифорния, Америка Кошмо Штаттары
SectorMedical device
Website-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
2,51 млд
2,87 млд
2,77 млд
2,89 млд
Cost of goods sold
842,70 млн
961,90 млн
940,30 млн
931,90 млн
Cost of revenue
842,70 млн
961,90 млн
940,30 млн
931,90 млн
Research and development expenses
329,40 млн
352,90 млн
361,90 млн
370,60 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
573,30 млн
687,10 млн
613,30 млн
617,90 млн
Operating expense
902,70 млн
1,04 млд
975,20 млн
988,50 млн
Total operating expenses
1,75 млд
2,00 млд
1,92 млд
1,92 млд
Operating income
759,70 млн
864,30 млн
855,30 млн
971,90 млн
Other non operating income
-
-
-
-
EBT including unusual items
855,20 млн
955,60 млн
940,40 млн
1,05 млд
EBT excluding unusual items
855,20 млн
950,90 млн
939,80 млн
1,05 млд
Income tax expense
146,00 млн
156,10 млн
114,40 млн
231,40 млн
Effective tax rate
17,07%
16,34%
12,16%
21,94%
Other operating expenses
-
-
-
-
Net income
704,40 млн
794,80 млн
821,50 млн
818,10 млн
Net profit margin
28,12%
27,73%
29,65%
28,29%
Earnings per share
2,40
2,53
2,50
2,80
Interest and investment income
82,30 млн
77,50 млн
85,70 млн
81,10 млн
Interest expense
-
-
-
-
Net interest expenses
82,30 млн
77,50 млн
85,70 млн
81,10 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
919,70 млн
1,02 млд
1,06 млд
1,20 млд
Gain or loss from assets sale
-
13,70 млн
-7,90 млн
-
AI content may include mistakes. Learn more
Google колдонмолору